FDA — authorised 29 December 1964
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: approved
🇺🇸 Lincocin in United States
FDA authorised Lincocin on 29 December 1964
Marketing authorisations
FDA — authorised 29 December 1964
- Application: NDA050316
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: LINCOCIN
- Indication: CAPSULE — ORAL
- Status: approved
FDA — authorised 29 December 1964
- Application: NDA050317
- Marketing authorisation holder: PFIZER
- Local brand name: LINCOCIN
- Indication: INJECTABLE — INJECTION
- Status: approved
Lincocin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Lincocin approved in United States?
Yes. FDA authorised it on 29 December 1964; FDA authorised it on 29 December 1964; FDA authorised it on 29 December 1964.
Who is the marketing authorisation holder for Lincocin in United States?
PHARMACIA AND UPJOHN holds the US marketing authorisation.